CRISM Therapeutics Corporation is a UK-based pharmaceutical company which has developed an innovative drug delivery technology, ChemoSeed, to improve the clinical performance of cancer treatments for solid tumours through the local delivery of chemotherapy. ChemoSeed will initially be used to treat glioblastoma, a brain tumour with no satisfactory treatment.
Company Details
- Employees
- 4
- Address
- The Unmet Medical Needs Of Patients With Rare Cancers And Other Diseases. Expedition Of Marketing Authorisation
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://www.crismtherapeutics.com
Crism Therapeutics Questions
Crism Therapeutics's website is http://www.crismtherapeutics.com
Crism Therapeutics's LinkedIn profile is https://www.linkedin.com/company/crism-therapeutics
Crism Therapeutics has
4 employees.
View email and phone details for 4
employees at Crism Therapeutics.
Crism Therapeutics's industry is
Pharmaceutical Manufacturing
Crism Therapeutics's top competitors are
Scancell,
Aixial Group,
Evolution Therapeutics Ltd,
Fortress Clinical Laboratory,
Excelya,
Bodyown,
Ormeau Clinical Trials Limited,
Heor,
Extruded Pharmaceuticals Ltd,
Imphatec Ltd.
Crism Therapeutics's categories are Pharmaceutical Manufacturing
